Teleflex Incorporated (TFX)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE
Market Cap: $6.15B
Last updated: Nov 17, 2026 at 11:06 AM ET
Teleflex Incorporated (TFX) Financials: Revenue, Profit and Cash Flow
Teleflex reported revenue of $1.99B for the fiscal year ended Dec 31, 2025, up 17.2% from the year before. That year, net income was -$905.64M with a net margin of -45.4%, operating cash flow was $96.68M and free cash flow was $1.45M. The quarter ended Sep 30, 2026 had revenue of $567.78M and net income of $927.43M.
Revenue and Margins
The operating margin was 5.9% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $1.87B, a compound annual rate of 0.7%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $1.99B | +17.2% | 56.2% | 5.9% | -45.4% |
| Dec 2024 | $1.70B | -0.8% | 61.0% | 6.1% | 4.1% |
| Dec 2023 | $1.71B | -38.6% | 60.7% | 15.1% | 20.8% |
| Dec 2022 | $2.79B | -0.7% | 54.9% | 17.9% | 13.0% |
| Dec 2021 | $2.81B | +10.7% | 55.2% | 22.4% | 17.3% |
| Dec 2020 | $2.54B | -2.2% | 52.2% | 16.7% | 13.2% |
| Dec 2019 | $2.60B | +6.0% | 54.3% | 16.5% | 17.8% |
| Dec 2018 | $2.45B | +14.1% | 53.2% | 13.1% | 8.2% |
| Dec 2017 | $2.15B | +14.9% | 54.6% | 17.3% | 7.1% |
| Dec 2016 | $1.87B | N/A | 53.3% | 17.1% | 12.7% |
Income Statement
In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.99B | $1.70B | $1.71B | $2.79B | $2.81B | $2.54B | $2.60B | $2.45B | $2.15B | $1.87B |
| Cost of revenue | $871.96M | $662.16M | $672.33M | $1.26B | $1.26B | $1.21B | $1.19B | $1.15B | $974.50M | $871.83M |
| Gross profit | $1.12B | $1.04B | $1.04B | $1.53B | $1.55B | $1.32B | $1.41B | $1.30B | $1.17B | $996.20M |
| Research and development | $144.78M | $109.02M | $113.63M | $153.82M | $130.84M | $119.75M | $113.86M | $106.21M | $84.77M | $58.58M |
| Operating income | $118.37M | $103.65M | $258.73M | $499.73M | $628.10M | $423.07M | $427.25M | $321.70M | $372.28M | $319.45M |
| Net income | -$905.64M | $69.67M | $356.33M | $363.14M | $485.37M | $335.32M | $461.47M | $200.80M | $152.53M | $237.84M |
| EBITDA | $300.79M | $268.60M | $410.23M | $734.37M | $869.95M | $654.75M | $645.62M | $536.42M | $532.62M | $447.80M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $567.78M | $570.33M | $548.26M | -$401.87M | $566.95M | $442.52M | $414.26M | -$552.37M | $764.38M | $749.69M | $737.85M | -$488.14M |
| Gross profit | $368.79M | $331.71M | $307.43M | -$151.41M | $292.05M | $265.83M | $255.43M | -$225.38M | $430.17M | $416.46M | $416.13M | -$175.40M |
| Operating income | $105.43M | $72.82M | $20.18M | $246.39M | -$62.44M | $91.14M | $75.80M | -$157.75M | $149.31M | $116.88M | -$4.79M | -$165.12M |
| Net income | $927.43M | $99.69M | -$8.15M | -$714.33M | -$408.89M | $122.58M | $95.00M | -$136.66M | $111.00M | $80.04M | $15.29M | $31.11M |
Balance Sheet
As of Dec 2025, total debt of $2.64B exceeded cash and equivalents by $2.26B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $6.95B | $7.10B | $7.53B | $6.93B | $6.87B | $7.15B | $6.31B | $6.28B | $6.18B | $3.89B |
| Current assets | $1.94B | $1.47B | $1.41B | $1.41B | $1.43B | $1.42B | $1.31B | $1.24B | $1.13B | $1.18B |
| Cash and equivalents | $378.56M | $247.85M | $222.85M | $292.03M | $445.08M | $375.88M | $301.08M | $357.16M | $333.56M | $543.79M |
| Total liabilities | $3.82B | $2.82B | $3.09B | $2.91B | $3.12B | $3.82B | $3.33B | $3.74B | $3.75B | $1.75B |
| Short-term debt | $100.00M | $100.00M | $87.50M | $87.50M | $110.00M | $100.50M | $198.09M | $223.50M | $160.85M | $183.66M |
| Long-term debt | $2.54B | $1.56B | $1.73B | $1.62B | $1.74B | $2.38B | $1.86B | $2.07B | $2.16B | $852.08M |
| Shareholder equity | $3.12B | $4.28B | $4.44B | $4.02B | $3.75B | $3.34B | $2.98B | $2.54B | $2.43B | $2.14B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $6.35B | $6.79B | $6.78B | $6.95B | $7.87B | $7.38B | $7.16B | $7.10B | $7.49B | $7.44B | $7.48B | $7.53B |
| Total liabilities | $2.85B | $3.88B | $3.70B | $3.82B | $4.05B | $3.13B | $3.07B | $2.82B | $3.00B | $2.88B | $2.97B | $3.09B |
| Cash and equivalents | $430.46M | $300.16M | $309.41M | $393.26M | $354.00M | $253.70M | $284.12M | $290.19M | $243.24M | $238.57M | $237.42M | $222.85M |
| Shareholder equity | $3.49B | $2.90B | $3.08B | $3.12B | $3.82B | $4.24B | $4.10B | $4.28B | $4.48B | $4.56B | $4.50B | $4.44B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 1.5% of operating cash flow. Dividends and share repurchases together came to 24846.2% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $96.68M | $301.88M | $206.14M | $342.81M | $652.14M | $437.14M | $437.07M | $435.09M | $426.30M | $410.59M |
| Capital expenditures | $95.24M | $90.44M | $46.42M | $79.19M | $71.62M | $90.69M | $102.69M | $80.80M | $70.90M | $53.13M |
| Free cash flow | $1.45M | $211.44M | $159.72M | $263.62M | $580.52M | $346.45M | $334.37M | $354.29M | $355.40M | $357.45M |
| Dividends paid | $60.27M | $63.54M | $63.90M | $63.79M | $63.65M | $63.22M | $62.83M | $62.16M | $61.24M | $59.42M |
| Share repurchases | $300.00M | $200.00M | $0 | $0 | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing cash flow | -$812.65M | -$63.36M | $27.26M | -$259.41M | $156.74M | -$837.78M | -$73.48M | -$196.39M | -$1.83B | -$56.97M |
| Financing cash flow | $611.54M | -$421.93M | $38.54M | -$217.51M | -$715.82M | $455.16M | -$418.84M | -$206.43M | $1.14B | -$118.69M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $96.28M | $91.90M | $46.66M | -$92.29M | $19.57M | -$37.02M | $27.72M | -$133.74M | $231.09M | $91.69M | $112.84M | -$166.22M |
| Capital expenditures | $21.61M | $14.03M | $18.79M | $651.00K | $19.50M | $27.79M | $24.13M | $3.98M | $21.18M | $34.80M | $38.43M | $17.35M |
| Free cash flow | $74.66M | $77.86M | $27.87M | -$92.94M | $69.00K | -$64.81M | $3.59M | -$137.72M | $209.91M | $56.89M | $74.41M | -$183.57M |
Frequently Asked Questions About TFX
What is Teleflex's annual revenue?
Teleflex reported revenue of $1.99B for the fiscal year ended Dec 31, 2025.
How fast is Teleflex's revenue growing?
Revenue was up 17.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -10.6%.
Is Teleflex profitable?
No. Teleflex reported net income of -$905.64M for the fiscal year ended Dec 31, 2025, with a net margin of -45.4%.
How much free cash flow does TFX generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $96.68M minus capital expenditures of $95.24M produced free cash flow of $1.45M.
How much debt does Teleflex have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $2.54B, short-term debt of $100.00M and cash and equivalents of $378.56M.
TFX pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts